Legend Biotech Q3 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $359.500M Miss $361.619M Estimate
Benzinga Newsdesk 18 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Legend Biotech (NASDAQ:LEGN) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 380 percent increase over losses of $(0.05) per share from
Legend Biotech (NASDAQ:LEGN) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 380 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $359.500 million which missed the analyst consensus estimate of $361.619 million by 0.59 percent. This is a 32.01 percent increase over sales of $272.330 million the same period last year.